ORAVESCENT Trademark

Trademark Overview

On Wednesday, March 21, 2012, a trademark application was filed for ORAVESCENT with the United States Patent and Trademark Office. The USPTO has given the ORAVESCENT trademark a serial number of 85575502. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 31, 2023. This trademark is owned by Cima Labs, Inc.. The ORAVESCENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of technology in the field of pharmaceutical tablets
oravescent

General Information

Serial Number85575502
Word MarkORAVESCENT
Filing DateWednesday, March 21, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 31, 2023
Registration Number5086847
Registration DateTuesday, November 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2013

Trademark Statements

Goods and ServicesDevelopment of technology in the field of pharmaceutical tablets

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 28, 2012
Primary Code042
First Use Anywhere DateThursday, January 15, 2009
First Use In Commerce DateThursday, January 15, 2009

Trademark Owner History

Party NameCima Labs, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrooklyn park, MN 55428
Party NameCima Labs, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrooklyn park, MN 55428
Party NameCima Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrooklyn park, MN 55428

Trademark Events

Event DateEvent Description
Wednesday, May 31, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, May 31, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, May 31, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 21, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, November 22, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 22, 2016REGISTERED-PRINCIPAL REGISTER
Friday, October 21, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 20, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 20, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 1, 2016USE AMENDMENT FILED
Thursday, September 1, 2016TEAS STATEMENT OF USE RECEIVED
Saturday, February 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2016SOU EXTENSION 5 GRANTED
Thursday, February 25, 2016SOU EXTENSION 5 FILED
Thursday, February 25, 2016TEAS EXTENSION RECEIVED
Saturday, August 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2015SOU EXTENSION 4 GRANTED
Thursday, August 27, 2015SOU EXTENSION 4 FILED
Thursday, August 27, 2015TEAS EXTENSION RECEIVED
Saturday, February 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 26, 2015SOU EXTENSION 3 GRANTED
Thursday, February 26, 2015SOU EXTENSION 3 FILED
Thursday, February 26, 2015TEAS EXTENSION RECEIVED
Friday, August 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 27, 2014SOU EXTENSION 2 GRANTED
Wednesday, August 27, 2014SOU EXTENSION 2 FILED
Wednesday, August 27, 2014TEAS EXTENSION RECEIVED
Friday, March 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 6, 2014SOU EXTENSION 1 GRANTED
Wednesday, February 26, 2014SOU EXTENSION 1 FILED
Wednesday, February 26, 2014TEAS EXTENSION RECEIVED
Friday, September 27, 2013CORRECTED NOA E-MAILED
Thursday, September 26, 2013DIVISIONAL PROCESSING COMPLETE
Tuesday, September 3, 2013DIVISIONAL REQUEST RECEIVED
Thursday, September 19, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 3, 2013TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 3, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 5, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 5, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 1, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 1, 2013FINAL REFUSAL E-MAILED
Friday, February 1, 2013FINAL REFUSAL WRITTEN
Monday, January 28, 2013DATA MODIFICATION COMPLETED
Monday, January 7, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 28, 2012ASSIGNED TO LIE
Thursday, December 20, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 28, 2012NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 28, 2012EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 28, 2012COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, June 28, 2012EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, June 26, 2012ASSIGNED TO EXAMINER
Wednesday, March 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 24, 2012NEW APPLICATION ENTERED

Related Keywords

oravescent tablets pharmaceutical field technology development